NCI 9671

Primary Category:

Cancer Control and Prevention Protocols

Disease Category:

Molecular Profiling, Other



Exceptional Responders Pilot study: Molecular profiling of tumors from cancer patients who are exceptional responders


All cases must be provisionally approved by NCI, before enrollment.  Once a case is approved by NCI, then the IRB approval process takes place. 

Due to the completion of accrual, new case proposal assignments to this protocol will be terminated July 10, 2017. As of July 11, 2017 no new case proposals will be accepted.